Search results
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 30 minutes agoRegeneron's innovation in biotechnology positions it well for future growth, despite industry...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 18 hours agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation - Regeneron ...
Benzinga· 10 hours agoOn Thursday, Regeneron Pharmaceuticals Inc REGN reported first-quarter adjusted EPS of $9.55, down...
Q1 2024 Regeneron Pharmaceuticals Inc Earnings Call Transcript
Guru Focus· 17 hours agoMay 02, 2024 / 12:30PM GMTOperator Welcome to the Regeneron Pharmaceuticals First Quarter 2024 Earnings Conference Call. My name is Josh, and I will be your ope
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 17 hours agoResearch and Development: R&D expenses increased by 13% to $1.248 billion, reflecting ongoing...
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
Morningstar· 19 hours agoBy Denny Jacob Regeneron Pharmaceuticals posted lower-than-expected revenue in its latest quarter which resulted in part from lower sales of EYLEA in the ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 16 hours agoRegeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due to...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 10 hours agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
Truist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 4 days agoTruist Financial Corp reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.4% in the fourth quarter, according ...
Checking in on Regeneron Pharmaceuticals, Inc.
Knox Daily· 2 days agoRegeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr 01 ...